1. Chronic lymphocytic leukaemia: from genetics to treatment;Bosch;Nat. Rev. Clin. Oncol.,2019
2. M. Hallek, B.D. Cheson, D. Catovsky, F. Caligaris-Cappio, G. Dighiero, H. Döhner, P. Hillmen, M. Keating, E. Montserrat, N. Chiorazzi, S. Stilgenbauer, K.R. Rai, J.C. Byrd, B. Eichhorst, S. O’Brien, T. Robak, J.F. Seymour, T.J. Kipps. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131 (2018) 2745–2760.
3. S.H. Swerdlow, E. Campo, S.A. Pileri, N.L. Harris, H. Stein, R. Siebert, R. Advani, M. Ghielmini, G.A. Salles, A.D. Zelenetz, E.S. Jaffe. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127 (2016) 2375–2390.
4. Chronic lymphocytic leukaemia;Hallek;Lancet,2018
5. Critical molecular pathways in CLL therapy;Ferrer;Mol. Med.,2018